Brokerages Set Allogene Therapeutics, Inc. (NASDAQ:ALLO) Price Target at $8.44
Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ten research firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average […]
Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ten research firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average […]
